Buy or sell Oxford Nanopore Technologies stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Oxford Nanopore Technologies Stock

Nanopore-based electronic systems

Founded

2005

Notable Investors

Lansdowne Partners

Total Funding

$275M

About Oxford Nanopore Technologies Stock

Oxford Nanopore Technologies Ltd. develops technologies for molecular detection and analysis in the United Kingdom. The company offers BASE technology, a system for DNA sequencing that employs nanopores to process, identify, and record DNA bases in sequence. Its technologies are used in DNA sequencing, diagnostics, drug development, biomolecular interaction, ion channel screening, and defense applications. The company was formerly known as Oxford NanoLabs, Ltd. and changed its name to Oxford Nanopore Technologies Ltd. in May 2008. Oxford Nanopore Technologies Ltd. was founded in 2005 and is based in Kidlington, the United Kingdom.

Investors

GT Healthcare Capital Partners

Oxford Nanopore Technologies

Woodford Investment Management

Oxford Nanopore Technologies

Funding History

May 2005$896K
May 2006$10.3M
March 2008$10.0M
April 2010$28.0M
April 2011$25.0M
May 2012$31.4M
October 2013$40.0M
August 2014$59.0M
July 2015$70.0M

Management

CEO

Gordon Sanghera

CSO

John Milton

CTO

Clive Brown

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Oxford Nanopore Technologies or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo